Innophos Holdings, Inc.  

(Public, NASDAQ:IPHS)   Watch this stock  
Find more results for Susan Myricks´┐Ż
27.11
-0.26 (-0.95%)
Feb 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 27.04 - 27.63
52 week 22.06 - 63.29
Open 27.14
Vol / Avg. 0.00/190,958.00
Mkt cap 516.60M
P/E 13.54
Div/yield 0.48/7.08
EPS 2.00
Shares 19.24M
Beta 0.91
Inst. own 92%
Feb 22, 2016
Q4 2015 Innophos Holdings Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 2.72% 7.68%
Operating margin 6.29% 12.73%
EBITD margin - 17.29%
Return on average assets 2.90% 8.75%
Return on average equity 5.98% 13.89%
Employees 1,445 -
CDP Score - -

Address

259 Prospect Plains Rd
CRANBURY, NJ 08512-3706
United States - Map
+1-609-4952495 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Innophos Holdings, Inc. is a producer of performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Bioactive mineral ingredients are mineral based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible. The Company has four product lines: Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA); Technical Grade Sodium Tripolyphosphate (STPP) and Detergent Grade PPA, and Granular Triple Super Phosphate (GTSP) and other. The Company also produces a range of botanical, enzyme and mineral-based ingredients through a variety of production processes customized through spray drying, roller compactions, grinding, wet granulations, solvent extractions and custom blending resulting in over 2,000 product formulations.

Officers and directors

Kim Ann Mink Ph.D. President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Mark Feuerbach Vice President - Investor Relations, Treasury, Financial Planning & Analysis, Interim Chief Financial Officer
Age: 55
Bio & Compensation  - Reuters
Louis Calvarin Chief Risk Officer, Vice President - Strategy
Age: 51
Bio & Compensation  - Reuters
William N. Farran Vice President, General Counsel, Corporate Secretary
Age: 65
Bio & Compensation  - Reuters
Abraham Shabot Vice President, General Manager Mexico and Latin America
Age: 53
Bio & Compensation  - Reuters
Charles Brodheim CPA, Vice President, Corporate Controller and Information Technology
Age: 51
Bio & Compensation  - Reuters
Gail Holler Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Joseph Golowski Vice President - Global Specialty Phosphates
Age: 53
Bio & Compensation  - Reuters
Mark Thurston Vice President - Nutrition and Business Development
Age: 55
Bio & Compensation  - Reuters
Susan Turner Vice President - Quality & Regulatory
Age: 61
Bio & Compensation  - Reuters